Survival disparities by age and country of diagnosis for patients with acute leukemia

References

• Pulte D, Gondos A, Brenner H. Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century. Blood 2009;113:1408–1411.
   PubMed Web of Science ®Google Scholar
• Pulte D, Gondos A, Brenner H. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990–2004. J Natl Cancer Inst 2008;100:1301–1309.
   PubMed Web of Science ®Google Scholar
• Storm HH, Klint A, Tryggvadottier L, et al. Trends in the survival of patients diagnosed with malignant neoplasms of lymphoid, haematopoietic, and related tissue in the Nordic countries 1964–2003 followed up to the end of 2006. Acta Oncol 2010;49:694–712.
   PubMed Web of Science ®Google Scholar
• Pulte D, Gondos A, Brenner H. Improvements in survival of adults diagnosed with acute myeloblastic leukemia in the early 21st century. Haematologica 2008;93:594–600.
   PubMed Web of Science ®Google Scholar
• Pulte D, Gondos A, Brenner H. Trends in survival after diagnosis with hematologic malignancy in adolescence or young adulthood in the United States, 1981–2005. Cancer 2009;115:4973–4979.
   PubMed Web of Science ®Google Scholar
• Pulte D, Gondos A, Brenner H. Expected long-term survival of patients diagnosed with acute myeloblastic leukemia during 2006–2010. Ann Oncol 2010;21:335–341.
   PubMed Web of Science ®Google Scholar
• Pulte D, Jansen L, Gondos A, et al. Survival in patients with acute myeloblastic leukemia in Germany and the United States: unexplained differences in survival in young adults. Haematologica 2013;98(Suppl. 1): Abstract 24.
   PubMed Web of Science ®Google Scholar
• Alvarnas JC, Brown PA, Aoun P, et al. Acute lymphoblastic leukemia. J Natl Compr Canc Newt 2012;10:858–914.
   PubMed Web of Science ®Google Scholar
• Grimwade D, Hills RK, Moorman AV, et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adults treated in the United Kingdom Medical Research Council trials. Blood 2010;116:354–365.
   PubMed Web of Science ®Google Scholar
• Brandwein IM, Gupta V, Wells RA, et al. Treatment of elderly patients with acute lymphoblastic leukemia—evidence for a benefit of imatinib in BCR-ABL positive patients. Leuk Res 2005;29:1381–1386.
   PubMed Web of Science ®Google Scholar
• Huguet F, Lequay T, Raffoux E, et al. Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study. J Clin Oncol 2009;27:911–918.
   PubMed Web of Science ®Google Scholar
• Martell MP, Atenafu EG, Minden MD, et al. Treatment of elderly patients with acute lymphoblastic leukaemia using a paediatric-based protocol. Br J Haematol 2013 Sept 13. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Wheatley K, Brookes CL, Howman AJ, et al. Prognostic factor analysis of the survival of elderly patients with AML in the MRC AML11 and LRF AML14 trials. Br J Haematol 2009;145:598–605.
   PubMed Web of Science ®Google Scholar
• Surveillance, Epidemiology, and End Results (SEER) Program. Research Data (1973–2010), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2013, based on the November 2012 submission. Available from: www.seer.cancer.gov
   Google Scholar
• Mariotto A, Capocaccia R, Verdecchia A, et al. Projecting SEER cancer survival rates to the US: an ecological regression approach. Cancer Causes Control 2002;13:101–111.
   PubMed Web of Science ®Google Scholar
• Office for National Statistics: Statistical bulletin: Annual mid-year population estimates for England and Wales, 2012. London: Office for National Statistics; 2013.
   Google Scholar
• Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations. Bethesda, MD: National Cancer Institute; 1959.
   Google Scholar
• Arias E. United States life tables, 2000. Natl Vit Stat Rep 2002;51(3):1–42.
   PubMedGoogle Scholar
• Brenner H, Gefeller O, Hakulinen T. Period analysis for up-to-date cancer survival data: theory, empirical evaluation, computational realization and applications. Eur J Cancer 2004;40:326–335.
   PubMed Web of Science ®Google Scholar
• Brenner H, Gefeller O. An alternative approach to monitoring cancer patient survival. Cancer 1996;78:2004–2010.
   PubMed Web of Science ®Google Scholar
• Brenner H, Soederman B, Hakulinen T. Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370,000 cancer patients in Finland. Int J Epidemiol 2002;31:456–462.
   PubMed Web of Science ®Google Scholar
• Brenner H, Hakulinen T. Up-to-date long-term survival curves of patients with cancer by period analysis. J Clin Oncol 2002;20:826–832.
   PubMed Web of Science ®Google Scholar
• Dickman PW, Sloggett A, Hills M, et al. Regression models for relative survival. Stat Med 2004;23:51–64.
   PubMed Web of Science ®Google Scholar
• Noble M, McLennan D, Wilkinson K, et al. The English incides of deprivation 2007. London: Department for Communities and Local Government; 2008.
   Google Scholar
• Stata statistical software: release 12. College Station, TX: StataCorp LP; 2011.
   Google Scholar
• Fast Stats: an interactive tool for access to SEER cancer statistics. Surveillance Research Program, National Cancer Institute. Available from: http://seer.cancer.gov/faststats
   Google Scholar
• Cancer Research UK. Acute myeloid leukaemia (AML) incidence statistics. Available from: www.cancerresearchuk.org/cancer-info/cancerstats/types/leukaemia-aml/incidence/
   Google Scholar
• De Labarthe A, Rousselot P, Huguet-Rigal F, et al. Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study. Blood 2007;109: 1408–1413.
   PubMed Web of Science ®Google Scholar
• Pulte D, Redaniel MT, Lowry L, et al. Age disparities in survival from lymphoma and myeloma: a comparison between the US and England. Br J Haematol 2014 Mar 29. [Epub ahead of print]
   Google Scholar
• Martin S, Ulrich C, Munsell M, et al. Delays in cancer diagnosis in underinsured young adults and older adolescents. Oncologist 2007;12:816–824.
   PubMed Web of Science ®Google Scholar
• Pulte D, Redaniel MT, Jansen L, et al. Recent trends in survival of adult patients with acute leukemia: overall improvements, but persistent and partly increasing disparity in survival of patients from minority groups. Haematologica 2013;98:222–229.
   PubMed Web of Science ®Google Scholar
• Bradley C, Dahman B, Jin Y, et al. Acute myeloid leukemia: how the uninsured fare. Cancer 2011;117:4772–4778.
   PubMed Web of Science ®Google Scholar
• Robbins AS, Pavluck AL, Fedewa SA, et al. Insurance status, comorbidity level, and survival among colorectal cancer patients age 18 to 64 years in the National Cancer Data Base from 2003 to 2005. J Clin Oncol 2009;27:3627–3633.
   PubMed Web of Science ®Google Scholar
• Estey EH. Acute myeloid leukemia and myelodysplastic syndrome in older patients. J Clin Oncol 2007;25:1908–1915.
   PubMed Web of Science ®Google Scholar
• Malfuson JV, Etienne A, Turlure P, et al. Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia. Haematologica 2008;93:1806–1813.
   PubMed Web of Science ®Google Scholar